BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 628416)

  • 21. Recommendations of DES Task Force.
    FDA Drug Bull; 1985 Dec; 15(4):40-2. PubMed ID: 4092908
    [No Abstract]   [Full Text] [Related]  

  • 22. [Exogenous estrogens and risk of breast cancer].
    Petersson BH
    Ugeskr Laeger; 1994 Apr; 156(16):2425-6. PubMed ID: 8009705
    [No Abstract]   [Full Text] [Related]  

  • 23. [Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem].
    Treffers PE; Hanselaar AG; Helmerhorst TJ; Koster ME; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):675-80. PubMed ID: 11530703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The tumor activity test].
    Czerniak P; Eylan E; Frenkel O; Sinkover A
    Harefuah; 1972 Jul; 83(1):5-10. PubMed ID: 4563872
    [No Abstract]   [Full Text] [Related]  

  • 25. Ties that bind. Mothers, daughters and sons continue to feel effects of DES.
    Tedeschi C
    Adv Nurse Pract; 1999 Nov; 7(11):28-34; quiz 35-6. PubMed ID: 10887780
    [No Abstract]   [Full Text] [Related]  

  • 26. Report of the recommendations of the 1985 DES Task Force of the U.S. Department of Health and Human Services.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):155-6, 161-2. PubMed ID: 3081782
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pregnancy after infiltrative breast cancer treatment: experience of the CHRU of Strasbourg with literature review].
    Kojouharova T; Arnould N; Favreau JJ; Gharbi M; Walther H; Youssef C; Gairard B; Mathelin C
    Gynecol Obstet Fertil; 2008; 36(7-8):757-66. PubMed ID: 18650118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Exposure to diethylstilbestrol during pregnancy as a cause for developmental abnormalities of the genitalia].
    Santti R; Mäkelä S; Pylkkänen L
    Duodecim; 1990; 106(18):1242-8. PubMed ID: 1670552
    [No Abstract]   [Full Text] [Related]  

  • 29. DES may be forgotten, but it's not gone.
    Health News; 2003 May; 9(5):9. PubMed ID: 12739463
    [No Abstract]   [Full Text] [Related]  

  • 30. Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period.
    Arriagada R; Le MG; Dunant A; Tubiana M; Contesso G
    Cancer; 2006 Feb; 106(4):743-50. PubMed ID: 16411216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of prenatal diethylstilbestrol (DES) exposure on the genitalia of pubertal Macaca mulatta. I. Female offspring.
    Hendrickx AG; Benirschke K; Thompson RS; Ahern JK; Lucas WE; Oi RH
    J Reprod Med; 1979 May; 22(5):233-40. PubMed ID: 458772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DES and breast cancer.
    FDA Drug Bull; 1978; 8(2):10. PubMed ID: 631466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Teratogenic and lethal actions of diethylstilbestrol on the mouse embryo].
    Gabriel-Robez O; Rohmer A; Clavert J; Schneegans E
    Arch Fr Pediatr; 1972 Feb; 29(2):149-54. PubMed ID: 5066437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormonal contraception and the growth of neoplasm].
    Haller J
    Med Klin; 1974 Feb; 69(7):272-86. PubMed ID: 4132852
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer risk among women exposed to exogenous estrogens during pregnancy.
    Hadjimichael OC; Meigs JW; Falcier FW; Thompson WD; Flannery JT
    J Natl Cancer Inst; 1984 Oct; 73(4):831-4. PubMed ID: 6592380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twenty-year review of a breast cancer screening project. Ninety-five percent survival of patients with nonpalpable cancers.
    Letton AH; Mason EM; Ramshaw BJ
    Cancer; 1996 Jan; 77(1):104-6. PubMed ID: 8630914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations of DES Task Force.
    NAACOG Newsl; 1986 Aug; 13(8):9-10. PubMed ID: 3092043
    [No Abstract]   [Full Text] [Related]  

  • 38. Excision only for tubular carcinoma of the breast.
    Leonard CE; Howell K; Shapiro H; Ponce J; Kercher J
    Breast J; 2005; 11(2):129-33. PubMed ID: 15730459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DES exposure and the aging woman: mothers and daughters.
    Laitman CJ
    Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy and benign breast disease.
    Trapido EJ; Brinton LA; Schairer C; Hoover R
    J Natl Cancer Inst; 1984 Nov; 73(5):1101-5. PubMed ID: 6092767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.